country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-183001

Copy Link Print Information

ATX-012

ATX-012 is an ionizable cationic lipid for the assembly of mRNA-delivering lipid nanoparticles (LNPs). ATX-012 blends with helper lipids, cholesterol and PEG-lipid conjugates to form mRNA-containing nanocarriers, which support efficient cellular internalization and the generation of functional proteins including CFTR. ATX-012 constitutes the vital building block of LNPs applied in cystic fibrosis-related biological studies.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 1777792-44-5
Formel: C₄₂H₇₈N₂O₅S
Molecular Weight:723.14

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

ATX-012 Chemical Structure

CAS. Nr.: 1777792-44-5

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

In Vitro

ATX-012 can form LNPs featuring high mRNA encapsulation efficiency (> 95%) and a small particle size ranging from 70 to 90 nm, and such LNPs achieve efficient mRNA delivery into lung epithelial cells in vitro and in vivo^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

ATX-012 (intratracheal administration)-formulated LNPs deliver mRNA to mouse lung epithelial cells and drive protein expression throughout large and small airways^[1].
ATX-012 (1 mg/kg; intranasal administration; once daily for two days)-based LNPs loaded with hCFTR mRNA restore functional chloride channel activity in CFTR knockout mice^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

CFTR knockout mice^[1]
Dosage:

1 mg/kg
Administration:

intranasal administration; once daily for two days
Result:

Restored functional chloride channel activity when loaded with hCFTR mRNA.

Chemical Information

CAS. Nr. 1777792-44-5
Molecular Weight 723.14
Formel C₄₂H₇₈N₂O₅S
SMILES

CCN(CCCSC(N(CCCCCCCC(OC/C=C\CCCCCC)=O)CCCCCCCC(OC/C=C\CCCCCC)=O)=O)CC
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Carlos G, et al. Lipid formulations containing nucleic acids and methods of treatment for cystic fibrosis. US20230159449A1. United States. 2022-11-03.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen